REG - Morgan Stanley Smith Allergan PLC - Form 8.3 - ALLERGAN PLC
RNS Number : 4866MMorgan Stanley Smith Barney LLC11 May 2020
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
Morgan Stanley Smith Barney LLC
Company dealt in
ALLERGAN PLC
Class of relevant security to which the
dealings being disclosed relate (Note 2)
US$0.0001 ORDINARY SHARES
Date of dealing
08 MAY 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
Long
Short
Number
(%)
Number
(%)
(1) Relevant securities
5,469,099
1.66
0
0.00
(2) Derivatives (other than options)
0
0.00
0
0.00
(3) Options and agreements to purchase/sell
0
0.00
1,500
0.00
Total
5,469,099
1.66
1,500
0.00
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 3)
_ Class of relevant security:
Long
Short
Number
(%)
Number
(%)
(1) Relevant securities
N/A
N/A
N/A
N/A
(2) Derivatives (other than options)
N/A
N/A
N/A
N/A
(3) Options and agreements to purchase/sell
N/A
N/A
N/A
N/A
Total
N/A
N/A
N/A
N/A
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 5)
PURCHASE
1
192.1000 USD
PURCHASE
2
192.1000 USD
PURCHASE
1
192.1062 USD
PURCHASE
3
192.1800 USD
PURCHASE
3
192.1800 USD
PURCHASE
25
192.2192 USD
PURCHASE
4
192.4800 USD
PURCHASE
3
192.5492 USD
PURCHASE
16
192.5492 USD
PURCHASE
2
192.5550 USD
PURCHASE
4
192.5584 USD
PURCHASE
3
192.5584 USD
PURCHASE
16
192.5584 USD
PURCHASE
14
192.5584 USD
PURCHASE
1
192.5600 USD
PURCHASE
5
192.6592 USD
PURCHASE
141
192.7158 USD
PURCHASE
1
192.7158 USD
PURCHASE
1
192.7158 USD
PURCHASE
1
192.7158 USD
PURCHASE
1
192.7158 USD
SALE
6
191.7958 USD
SALE
18
191.7958 USD
SALE
16
191.7958 USD
SALE
7
191.7958 USD
SALE
17
191.7958 USD
SALE
6
191.7958 USD
SALE
6
191.7958 USD
SALE
6
191.7958 USD
SALE
5
191.7958 USD
SALE
6
191.7958 USD
SALE
10
191.7958 USD
SALE
4
191.7958 USD
SALE
17
191.7958 USD
SALE
16
191.7958 USD
SALE
13
191.7958 USD
SALE
4
191.7958 USD
SALE
6
191.7958 USD
SALE
330
191.7958 USD
SALE
7
191.7958 USD
SALE
6
191.7958 USD
SALE
4
191.7958 USD
SALE
6
191.7958 USD
SALE
9
191.7958 USD
SALE
8
191.7958 USD
SALE
4
191.7958 USD
SALE
8
191.7958 USD
SALE
17
191.7958 USD
SALE
13
191.7958 USD
SALE
101
191.7958 USD
SALE
5
191.7958 USD
SALE
9
191.7958 USD
SALE
16
191.7958 USD
SALE
5
191.7958 USD
SALE
6
191.7958 USD
SALE
5
191.7958 USD
SALE
16
191.7958 USD
SALE
7
191.7958 USD
SALE
6
191.7958 USD
SALE
4
191.7958 USD
SALE
7
191.7958 USD
SALE
16
191.7958 USD
SALE
6
191.7958 USD
SALE
12
191.7958 USD
SALE
8
191.7958 USD
SALE
3
191.7958 USD
SALE
4
191.7958 USD
SALE
5
191.7958 USD
SALE
39
191.7958 USD
SALE
24
191.7958 USD
SALE
9
191.7958 USD
SALE
5
191.7958 USD
SALE
9
191.7958 USD
SALE
9
191.7958 USD
SALE
9
191.7958 USD
SALE
5
191.7958 USD
SALE
9
191.7958 USD
SALE
9
191.7958 USD
SALE
28
191.7958 USD
SALE
44
191.7958 USD
SALE
5
191.7958 USD
SALE
15
191.7958 USD
SALE
6
191.7958 USD
SALE
17
191.7958 USD
SALE
3
191.7958 USD
SALE
6
191.7958 USD
SALE
6
191.7958 USD
SALE
5
191.7958 USD
SALE
7
191.7958 USD
SALE
20
191.7958 USD
SALE
7
191.7958 USD
SALE
11
191.7958 USD
SALE
13
191.7958 USD
SALE
9
191.7958 USD
SALE
7
191.7958 USD
SALE
23
191.7958 USD
SALE
4
191.7958 USD
SALE
8
191.7958 USD
SALE
9
191.7958 USD
SALE
4
191.7958 USD
SALE
4
191.7958 USD
SALE
5
191.7958 USD
SALE
1
191.7958 USD
SALE
16
191.7958 USD
SALE
11
191.7958 USD
SALE
9
191.7958 USD
SALE
17
191.7958 USD
SALE
10
191.7958 USD
SALE
6
191.7958 USD
SALE
11
191.7958 USD
SALE
13
191.7958 USD
SALE
6
191.7958 USD
SALE
16
191.7958 USD
SALE
12
191.7958 USD
SALE
20
191.7958 USD
SALE
5
191.7958 USD
SALE
9
191.7958 USD
SALE
7
191.7958 USD
SALE
7
191.7958 USD
SALE
6
191.7958 USD
SALE
6
191.7958 USD
SALE
8
191.7958 USD
SALE
8
191.7958 USD
SALE
8
191.7958 USD
SALE
11
191.7958 USD
SALE
8
191.7958 USD
SALE
4
191.7958 USD
SALE
5
191.7958 USD
SALE
25
191.7958 USD
SALE
11
191.7958 USD
SALE
16
191.7958 USD
SALE
11
191.7958 USD
SALE
9
191.7958 USD
SALE
5
191.7958 USD
SALE
9
191.7958 USD
SALE
13
191.7958 USD
SALE
12
191.7958 USD
SALE
9
191.7958 USD
SALE
8
191.7958 USD
SALE
4
191.7958 USD
SALE
11
191.7958 USD
SALE
7
191.7958 USD
SALE
12
191.7958 USD
SALE
9
191.7958 USD
SALE
13
191.7958 USD
SALE
4
191.7958 USD
SALE
7
191.7958 USD
SALE
5
191.7958 USD
SALE
6
191.7958 USD
SALE
8
191.7958 USD
SALE
15
191.7958 USD
SALE
7
191.7958 USD
SALE
10
191.7958 USD
SALE
53
191.7958 USD
SALE
9
191.7958 USD
SALE
16
191.7958 USD
SALE
10
191.7958 USD
SALE
6
191.7958 USD
SALE
9
191.7958 USD
SALE
13
191.7958 USD
SALE
6
191.7958 USD
SALE
12
191.7958 USD
SALE
6
191.7958 USD
SALE
6
191.7958 USD
SALE
7
191.7958 USD
SALE
4
191.7958 USD
SALE
12
191.7958 USD
SALE
10
191.7958 USD
SALE
7
191.7958 USD
SALE
4
191.7958 USD
SALE
9
191.7958 USD
SALE
11
191.7958 USD
SALE
6
191.7958 USD
SALE
7
191.7958 USD
SALE
6
191.7958 USD
SALE
6
191.7958 USD
SALE
10
191.7958 USD
SALE
22
191.7958 USD
SALE
34
191.7958 USD
SALE
8
191.7958 USD
SALE
4
191.7958 USD
SALE
4
191.7958 USD
SALE
14
191.7958 USD
SALE
5
191.7958 USD
SALE
5
191.7958 USD
SALE
7
191.7958 USD
SALE
7
191.7958 USD
SALE
5
191.7958 USD
SALE
4
191.7958 USD
SALE
6
191.7958 USD
SALE
12
191.7958 USD
SALE
5
191.7958 USD
SALE
8
191.7958 USD
SALE
6
191.7958 USD
SALE
7
191.7958 USD
SALE
14
191.7958 USD
SALE
7
191.7958 USD
SALE
7
191.7958 USD
SALE
23
191.7958 USD
SALE
27
191.7958 USD
SALE
9
191.7958 USD
SALE
8
191.7958 USD
SALE
5
191.7958 USD
SALE
5
191.7958 USD
SALE
8
191.7958 USD
SALE
4
191.7958 USD
SALE
23
191.7958 USD
SALE
9
191.7958 USD
SALE
9
191.7958 USD
SALE
7
191.7958 USD
SALE
5
191.7958 USD
SALE
7
191.7958 USD
SALE
4
191.7958 USD
SALE
6
191.7958 USD
SALE
5
191.7958 USD
SALE
8
191.7958 USD
SALE
7
191.7958 USD
SALE
3
191.7958 USD
SALE
4
191.7958 USD
SALE
7
191.7958 USD
SALE
22
191.7958 USD
SALE
7
191.7958 USD
SALE
8
191.7958 USD
SALE
4
191.7958 USD
SALE
4
191.7958 USD
SALE
4
191.7958 USD
SALE
6
191.7958 USD
SALE
5
191.7958 USD
SALE
10
191.7958 USD
SALE
10
191.7958 USD
SALE
5
191.7958 USD
SALE
6
191.7958 USD
SALE
4
191.7958 USD
SALE
10
191.7958 USD
SALE
15
191.7958 USD
SALE
7
191.7958 USD
SALE
6
191.7958 USD
SALE
5
191.7958 USD
SALE
3
191.7958 USD
SALE
1
191.7958 USD
SALE
5
191.7958 USD
SALE
6
191.7958 USD
SALE
1
191.7958 USD
SALE
8
191.7958 USD
SALE
6
191.7958 USD
SALE
6
191.7958 USD
SALE
58
191.7958 USD
SALE
20
191.7958 USD
SALE
21
191.7958 USD
SALE
8
191.7958 USD
SALE
4
191.7958 USD
SALE
5
191.7958 USD
SALE
16
191.7958 USD
SALE
14
191.7958 USD
SALE
20
191.7958 USD
SALE
34
191.7958 USD
SALE
13
191.7958 USD
SALE
26
191.7958 USD
SALE
65
191.7958 USD
SALE
15
191.7958 USD
SALE
15
191.7958 USD
SALE
11
191.7958 USD
SALE
12
191.7958 USD
SALE
18
191.7958 USD
SALE
7
191.7958 USD
SALE
19
191.7958 USD
SALE
11
191.7958 USD
SALE
14
191.7958 USD
SALE
166
191.7958 USD
SALE
19
191.7958 USD
SALE
4
191.7958 USD
SALE
4
191.7958 USD
SALE
12
191.7958 USD
SALE
12
191.7958 USD
SALE
7
191.7958 USD
SALE
5
191.7958 USD
SALE
5
191.7958 USD
SALE
8
191.7958 USD
SALE
14
191.7958 USD
SALE
9
191.7958 USD
SALE
22
191.7958 USD
SALE
107
191.7958 USD
SALE
24
191.7958 USD
SALE
17
191.7958 USD
SALE
12
191.7958 USD
SALE
79
191.7958 USD
SALE
139
191.7958 USD
SALE
144
191.7958 USD
SALE
23
191.7958 USD
SALE
10
191.7958 USD
SALE
132
191.7958 USD
SALE
10
191.7958 USD
SALE
17
191.7958 USD
SALE
58
191.7958 USD
SALE
34
191.7958 USD
SALE
54
191.7958 USD
SALE
17
191.7958 USD
SALE
12
191.7958 USD
SALE
11
191.7958 USD
SALE
24
191.7958 USD
SALE
14
191.7958 USD
SALE
34
191.7958 USD
SALE
10
191.7958 USD
SALE
31
191.7958 USD
SALE
10
191.7958 USD
SALE
15
191.7958 USD
SALE
10
191.7958 USD
SALE
10
191.7958 USD
SALE
9
191.7958 USD
SALE
81
191.7958 USD
SALE
13
191.7958 USD
SALE
9
191.7958 USD
SALE
13
191.7958 USD
SALE
33
191.7958 USD
SALE
24
191.7958 USD
SALE
542
191.7958 USD
SALE
32
191.8600 USD
SALE
30
192.0793 USD
SALE
8
192.1046 USD
SALE
4
192.1116 USD
SALE
20
192.1200 USD
SALE
1
192.1200 USD
SALE
4
192.1200 USD
SALE
57
192.1300 USD
SALE
3
192.1900 USD
SALE
145
192.2547 USD
SALE
23
192.4308 USD
SALE
10
192.4400 USD
SALE
2
192.4408 USD
SALE
14
192.5300 USD
SALE
7
192.5331 USD
SALE
5
192.5350 USD
SALE
117
192.5359 USD
SALE
8
192.5359 USD
SALE
24
192.5414 USD
SALE
19
192.5414 USD
SALE
89
192.5414 USD
SALE
35
192.5414 USD
SALE
67
192.5414 USD
SALE
37
192.5414 USD
SALE
50
192.5414 USD
SALE
151
192.5414 USD
SALE
10
192.5414 USD
SALE
12
192.5414 USD
SALE
45
192.5414 USD
SALE
45
192.5438 USD
SALE
111
192.5467 USD
SALE
35
192.5467 USD
SALE
54
192.5467 USD
SALE
162
192.5467 USD
SALE
186
192.5467 USD
SALE
23
192.5467 USD
SALE
88
192.5467 USD
SALE
31
192.5467 USD
SALE
7
192.5500 USD
SALE
4
192.5500 USD
SALE
4
192.5550 USD
SALE
35
192.5587 USD
SALE
35
192.6000 USD
SALE
27
192.6047 USD
SALE
20
192.6500 USD
SALE
3
192.6905 USD
SALE
6
192.6905 USD
SALE
140
192.7158 USD
SALE
43
192.9110 USD
SALE
62
192.9110 USD
(b) Derivatives transactions(other than options transactions)
Product name, e.g. CFD
Nature of transaction
(Note 6)
Number of relevant securities
(Note 7)
Price per unit
(Note 5)
N/A
N/A
N/A
N/A
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc
Number of securities to which the option relates
(Note 7)
Exercise
Price
Type, e.g.
American,
European etc
Expiry
Date
Option money
paid/received
per unit
(Note 5)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per
unit (Note 5)
N/A
N/A
N/A
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8)
Details
Price per unit
(if applicable) (Note 5)
N/A
N/A
N/A
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE
Is a Supplemental Form 8 attached? (Note 9)
YES
Date of disclosure
11 MAY 2020
Contact Name
Craig Horsley
Telephone Number
+44(141) 245 7736
If a connected EFM, name of offeree/offeror with which connected
ABBVIE INC.
If a connected EFM, state nature of connection (Note 10)
Advisory
Notes
1. Specify the owner or controller of the interest in addition to the person dealing. The naming of nominees or vehicle companies is insufficient. In case of disclosure of dealings by fund managers on behalf of discretionary clients, the clients need not be named.
2. See the definition of 'relevant securities' in Rule 2.1 of part A of the Rules.
3. See the definition of 'interest in relevant security' in Rule 2.6 of part A of the Rules and see Rules 8.6(a) of Part B of the Rules. If an option over new securities is acquired or exercised, the relevant interest should be disclosed under "(1) Relevant Securities". If an option over existing relevant securities is acquired or exercised, the relevant interest should be disclosed under "(3) Options and agreements to purchase/sell".
4. See the definition of 'dealing' in Rule 2.1 of part A of the Rules.
5. For all prices and other monetary amounts, the currency must be stated. If economic exposure to the changes in the price of the securities is limited, for example, by virtue of stop loss arrangement relating to spread bet, full details must be given.
6. If a long position has been increased or decreased as a result of the dealing, write "increased long" or "decreased long" respectively. If a short position has been increased or decreased as a result of the dealing, write "increased short" or "decreased short" respectively. If the dealing has not resulted in a long or short position being increased or reduced, give details of the variation or other dealing.
7. See Rule 2.6(d) of Part A of the Rules .
8. State type of dealing, e.g. "subscription", "conversion", "exercise" etc .
9. Where there are open option positions or open derivative positions (other than CFDs), or where there is an agreement to purchase or to sell, Supplemental Form 8 must be completed.
10. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2013.
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 and 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) and Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product Name
e.g. call option
Written or Purchased
Number of relevant securities to which
the option or
derivative relates
Exercise
Price
(Note 2)
Type, e.g.
American,
European etc.
Expiry
Date
CALL
WRITTEN
100
195.00 USD
American
21/08/2020
CALL
WRITTEN
100
175.00 USD
American
19/06/2020
CALL
WRITTEN
200
190.00 USD
American
19/06/2020
CALL
WRITTEN
200
170.00 USD
American
19/06/2020
CALL
WRITTEN
100
210.00 USD
American
15/01/2021
CALL
WRITTEN
200
175.00 USD
American
15/01/2021
CALL
WRITTEN
300
175.00 USD
American
15/01/2021
CALL
WRITTEN
200
175.00 USD
American
15/01/2021
CALL
WRITTEN
100
190.00 USD
American
15/05/2020
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated .
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISESFMSUFESSEEI
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement